| 1 | Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease. (Alexanian AR, Sorokin A, Duersteler M) J Neurol Sci 2024 Oct 15;465:123188 |
| 3 | Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease. (Cheng G, Hardy M, Hillard CJ, Feix JB, Kalyanaraman B) Commun Biol 2024 May 30;7(1):668 1 Citation |
| 2 | Parkinson's disease is associated with low striated esophagus contractility potentially contributing to the development of dysphagia. (Kerschner A, Hassan H, Kern M, Edeani F, Mei L, Sanvanson P, Shaker R, Yu E) Neurogastroenterol Motil 2024 Aug;36(8):e14822 |
| 3 | Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications. (Kalyanaraman B, Cheng G, Hardy M) Redox Biol 2024 May;71:103092 22 Citations |
| 1 | Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. (Duffley G, Szabo A, Lutz BJ, Mahoney-Rafferty EC, Hess CW, Ramirez-Zamora A, Zeilman P, Foote KD, Chiu S, Pourfar MH, Goas Cnp C, Wood JL, Haq IU, Siddiqui MS, Afshari M, Heiry M, Choi J, Volz M, Ostrem JL, San Luciano M, Niemann N, Billnitzer A, Savitt D, Tarakad A, Jimenez-Shahed J, Aquino CC, Okun MS, Butson CR) Parkinsonism Relat Disord 2023 Apr;109:105346 3 Citations |
| 1 | Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs. (Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, Lankri D, Duggan P, Nazarova AL, Cao AB, Calkins MM, Khirsariya P, Hwu C, Katritch V, Chandra SS, McCorvy JD, Sames D) ACS Chem Neurosci 2023 Jan 04;14(1):119-135 27 Citations |
| 1 | Laterality of the activation of the vastus lateralis muscle in females with Parkinson's disease during the medication state compared with healthy controls. (Nishikawa Y, Watanabe K, Takahashi T, Maeda N, Maruyama H, Tanaka S, Hyngstrom A) J Integr Neurosci 2022 Jan 28;21(1):40 3 Citations |
| 2 | The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease. (Yu H, Liu X, Chen B, Vickstrom CR, Friedman V, Kelly TJ, Bai X, Zhao L, Hillard CJ, Liu QS) Cells 2021 Dec 16;10(12) 24 Citations |
| 1 | Association between the Degree of Pre-Synaptic Dopaminergic Pathway Degeneration and Motor Unit Firing Behavior in Parkinson's Disease Patients. (Nishikawa Y, Watanabe K, Holobar A, Takahashi T, Maeda N, Maruyama H, Tanaka S, Hyngstrom AS) Sensors (Basel) 2021 Oct 04;21(19) 3 Citations |
| 1 | Modulating α-Synuclein Liquid-Liquid Phase Separation. (Sawner AS, Ray S, Yadav P, Mukherjee S, Panigrahi R, Poudyal M, Patel K, Ghosh D, Kummerant E, Kumar A, Riek R, Maji SK) Biochemistry 2021 Dec 07;60(48):3676-3696 82 Citations |
| 1 | Traumatic Brain Injury and Risk of Neurodegenerative Disorder. (Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD) Biol Psychiatry 2022 Mar 01;91(5):498-507 190 Citations |
| 1 | Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial. (Duffley G, Lutz BJ, Szabo A, Wright A, Hess CW, Ramirez-Zamora A, Zeilman P, Chiu S, Foote KD, Okun MS, Butson CR) JAMA Neurol 2021 Aug 01;78(8):972-981 16 Citations |
| 1 | Freezing of Gait in Parkinson's Disease: Invasive and Noninvasive Neuromodulation. (Rahimpour S, Gaztanaga W, Yadav AP, Chang SJ, Krucoff MO, Cajigas I, Turner DA, Wang DD) Neuromodulation 2021 Jul;24(5):829-842 34 Citations |
| 1 | Effect of Disease-Associated P123H and V70M Mutations on β-Synuclein Fibrillation. (Sharma K, Mehra S, Sawner AS, Markam PS, Panigrahi R, Navalkar A, Chatterjee D, Kumar R, Kadu P, Patel K, Ray S, Kumar A, Maji SK) ACS Chem Neurosci 2020 Sep 16;11(18):2836-2848 12 Citations |
| 1 | Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease. (Kalyanaraman B) Redox Biol 2020 Sep;36:101665 27 Citations |
| 1 | Caregiver burden worsens in the second year after subthalamic nucleus deep brain stimulation for Parkinson's disease. (Jackowiak E, Maher AC, Persad C, Kotagal V, Wyant K, Heston A, Patil PG, Chou KL) Parkinsonism Relat Disord 2020 Sep;78:4-8 8 Citations |
| 1 | α-Synuclein aggregation nucleates through liquid-liquid phase separation. (Ray S, Singh N, Kumar R, Patel K, Pandey S, Datta D, Mahato J, Panigrahi R, Navalkar A, Mehra S, Gadhe L, Chatterjee D, Sawner AS, Maiti S, Bhatia S, Gerez JA, Chowdhury A, Kumar A, Padinhateeri R, Riek R, Krishnamoorthy G, Maji SK) Nat Chem 2020 Aug;12(8):705-716 463 Citations |
| 1 | Dopamine β Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India. (Ghosh A, Sadhukhan T, Giri S, Biswas A, Das SK, Ray K, Ray J) Neurosci Lett 2019 Jul 27;706:75-80 12 Citations |
| 1 | The Deep Brain Stimulation "Twiddler Syndrome". (Jackowiak E, Patil PG, Chou KL) JAMA Neurol 2019 May 01;76(5):620 5 Citations |
| 1 | Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes. (Sison SL, Vermilyea SC, Emborg ME, Ebert AD) Curr Neurol Neurosci Rep 2018 Oct 04;18(12):84 37 Citations |
| 1 | Decreased NAD+ in dopaminergic neurons. (Sison SL, Ebert AD) Aging (Albany NY) 2018 Apr 28;10(4):526-527 6 Citations |
| 1 | Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. (Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J, International Parkinson’s Disease Genomics Consortium (IPDGC), Heutink P, Shulman JM) Brain 2017 Dec 01;140(12):3191-3203 315 Citations |
| 2 | Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons. (Schwab AJ, Sison SL, Meade MR, Broniowska KA, Corbett JA, Ebert AD) Stem Cell Reports 2017 Dec 12;9(6):1839-1852 71 Citations |
| 3 | Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice. (Langley M, Ghosh A, Charli A, Sarkar S, Ay M, Luo J, Zielonka J, Brenza T, Bennett B, Jin H, Ghaisas S, Schlichtmann B, Kim D, Anantharam V, Kanthasamy A, Narasimhan B, Kalyanaraman B, Kanthasamy AG) Antioxid Redox Signal 2017 Nov 10;27(14):1048-1066 104 Citations |
| 1 | Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis. (Bozymski KM, Lowe DK, Pasternak KM, Gatesman TL, Crouse EL) Ann Pharmacother 2017 Jun;51(6):479-487 34 Citations |
| 1 | Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing. (Jansen IE, Ye H, Heetveld S, Lechler MC, Michels H, Seinstra RI, Lubbe SJ, Drouet V, Lesage S, Majounie E, Gibbs JR, Nalls MA, Ryten M, Botia JA, Vandrovcova J, Simon-Sanchez J, Castillo-Lizardo M, Rizzu P, Blauwendraat C, Chouhan AK, Li Y, Yogi P, Amin N, van Duijn CM, International Parkinson’s Disease Genetics Consortium (IPGDC), Morris HR, Brice A, Singleton AB, David DC, Nollen EA, Jain S, Shulman JM, Heutink P) Genome Biol 2017 Jan 30;18(1):22 85 Citations |
| 1 | Freezing of gait is associated with increased saccade latency and variability in Parkinson's disease. (Nemanich ST, Earhart GM) Clin Neurophysiol 2016 Jun;127(6):2394-401 31 Citations |
| 2 | Non-Infectious Peri-Electrode Edema and Contrast Enhancement Following Deep Brain Stimulation Surgery. (Arocho-Quinones EV, Pahapill PA) Neuromodulation 2016 Dec;19(8):872-876 21 Citations |
| 1 | Oropharyngeal dysphagia in older persons - from pathophysiology to adequate intervention: a review and summary of an international expert meeting. (Wirth R, Dziewas R, Beck AM, Clavé P, Hamdy S, Heppner HJ, Langmore S, Leischker AH, Martino R, Pluschinski P, Rösler A, Shaker R, Warnecke T, Sieber CC, Volkert D) Clin Interv Aging 2016;11:189-208 359 Citations |
| 1 | Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation. (Schwab AJ, Ebert AD) Stem Cell Reports 2015 Dec 08;5(6):1039-1052 74 Citations |
| 1 | Reduced after-effects following podokinetic adaptation in people with Parkinson's disease and freezing of gait. (Nemanich ST, Earhart GM) Parkinsonism Relat Disord 2016 Jan;22:93-7 3 Citations |
| 1 | Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease. (Rivero-Ríos P, Gómez-Suaga P, Fernández B, Madero-Pérez J, Schwab AJ, Ebert AD, Hilfiker S) Biochem Soc Trans 2015 Jun;43(3):390-5 27 Citations |
| 1 | Prism adaptation in Parkinson disease: comparing reaching to walking and freezers to non-freezers. (Nemanich ST, Earhart GM) Exp Brain Res 2015 Aug;233(8):2301-10 7 Citations |
| 1 | Neuropsychological findings in a case of punding before and after cessation of pramipexole. (Larson ER) Clin Neuropsychol 2015;29(1):166-78 1 Citation |
| 1 | Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. (Hockey LN, Kilpatrick BS, Eden ER, Lin-Moshier Y, Brailoiu GC, Brailoiu E, Futter CE, Schapira AH, Marchant JS, Patel S) J Cell Sci 2015 Jan 15;128(2):232-8 150 Citations |
| 3 | A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease. (Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL, Stucky CL, Kanthasamy AG, Kalyanaraman B) Neurosci Lett 2014 Nov 07;583:159-64 45 Citations |
| 1 | Emergence of deglutology: a transdisciplinary field. (Babaei A, Shaker R) Clin Gastroenterol Hepatol 2014 Dec;12(12):2046-8 |
| 1 | Dietary fat intake and risk for Parkinson's disease. (Dong J, Beard JD, Umbach DM, Park Y, Huang X, Blair A, Kamel F, Chen H) Mov Disord 2014 Nov;29(13):1623-30 36 Citations |
| 1 | Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. (Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R, International Parkinson's Disease Genomics Consortium (IPDGC), Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Ashkenazi Jewish Dataset Investigator, Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson's Disease Consortium, Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB) Nat Genet 2014 Sep;46(9):989-93 1470 Citations |
| 1 | A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. (Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K) JAMA Neurol 2014 May;71(5):543-52 321 Citations |
| 1 | Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. (Dong J, Gao J, Nalls M, Gao X, Huang X, Han J, Singleton AB, Chen H, International Parkinson’s Disease Genomics Consortium (IPDGC)) Neurobiol Aging 2014 Jun;35(6):1512.e5-1512.e10 30 Citations |
| 1 | Neuropathology indicates a need for earlier neurorestorative intervention in Parkinson's disease. (Zwagerman NT, Richardson RM) Neurosurgery 2013 Dec;73(6):N14-5 1 Citation |
| 1 | Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. (Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG) Biochim Biophys Acta 2014 Aug;1842(8):1282-94 283 Citations |
| 2 | Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse. (Dranka BP, Gifford A, Ghosh A, Zielonka J, Joseph J, Kanthasamy AG, Kalyanaraman B) Neurosci Lett 2013 Aug 09;549:57-62 31 Citations |
| 2 | Where is the action? Action sentence processing in Parkinson's disease. (Fernandino L, Conant LL, Binder JR, Blindauer K, Hiner B, Spangler K, Desai RH) Neuropsychologia 2013 Jul;51(8):1510-7 100 Citations |
| 2 | Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. (DeSantis ME, Leung EH, Sweeny EA, Jackrel ME, Cushman-Nick M, Neuhaus-Follini A, Vashist S, Sochor MA, Knight MN, Shorter J) Cell 2012 Nov 09;151(4):778-793 144 Citations |
| 2 | Parkinson's disease disrupts both automatic and controlled processing of action verbs. (Fernandino L, Conant LL, Binder JR, Blindauer K, Hiner B, Spangler K, Desai RH) Brain Lang 2013 Oct;127(1):65-74 136 Citations |
| 1 | Therapeutic effect of near infrared (NIR) light on Parkinson's disease models. (Quirk BJ, Desmet KD, Henry M, Buchmann E, Wong-Riley M, Eells JT, Whelan HT) Front Biosci (Elite Ed) 2012 Jan 01;4(3):818-23 39 Citations |
| 1 | Clinical predictors of frequent patient telephone calls in Parkinson's disease. (Liu AA, Boxhorn CE, Klufas MA, Christos PJ, Thorne JT, Shih AY, Tsankova NM, Dorfman BJ, Henchcliffe C, Piboolnurak P, Nirenberg MJ) Parkinsonism Relat Disord 2011 Feb;17(2):95-9 18 Citations |
| 1 | Intraoperative local field recording for deep brain stimulation in Parkinson's disease and essential tremor. (Holdefer RN, Cohen BA, Greene KA) Mov Disord 2010 Oct 15;25(13):2067-75 20 Citations |
| 1 | Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. (Esteves AR, Lu J, Rodova M, Onyango I, Lezi E, Dubinsky R, Lyons KE, Pahwa R, Burns JM, Cardoso SM, Swerdlow RH) J Neurochem 2010 May;113(3):674-82 69 Citations |
| 2 | Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease. (Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B) Free Radic Biol Med 2010 Feb 01;48(3):377-83 41 Citations |
| 1 | Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity. (Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT) Brain Res 2008 Dec 03;1243:167-73 99 Citations |
| 1 | Many forkheads in the road to regulation. Symposium on forkhead transcription factor networks in development, signalling and disease. (Cirillo LA, Barton MC) EMBO Rep 2008 Aug;9(8):721-4 10 Citations |
| 1 | Linking SIRT2 to Parkinson's disease. (Garske AL, Smith BC, Denu JM) ACS Chem Biol 2007 Aug 17;2(8):529-32 62 Citations |
| 1 | Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. (Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN) J Neurosci Methods 2007 Jul 30;163(2):338-49 69 Citations |
| 1 | Can you take care of my mother? Reflections on cultural competency and clinical accommodation. (Padela AI) Acad Emerg Med 2007 Mar;14(3):275-7 13 Citations |
| 1 | Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. (Bordini BJ, Garg A, Gallagher CL, Bell B, Garell PC) Stereotact Funct Neurosurg 2007;85(2-3):113-20 19 Citations |
| 1 | Association of dopamine agonist use with impulse control disorders in Parkinson disease. (Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB) Arch Neurol 2006 Jul;63(7):969-73 581 Citations |
| 1 | Altered coordination patterns in parkinsonian patients during trunk-assisted prehension. (Wang J, Bohan M, Leis BC, Stelmach GE) Parkinsonism Relat Disord 2006 May;12(4):211-22 10 Citations |
| 1 | Deep brain stimulation of the subthalamic nucleus in Parkinson's disease. (Kawakami N, Jessen H, Bordini B, Gallagher C, Klootwyk J, Garell CP) WMJ 2005 Aug;104(6):35-8 9 Citations |
| 1 | Laryngeal findings in advanced Parkinson's disease. (Blumin JH, Pcolinsky DE, Atkins JP) Ann Otol Rhinol Laryngol 2004 Apr;113(4):253-8 75 Citations |
| 2 | 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. (Shang T, Kotamraju S, Kalivendi SV, Hillard CJ, Kalyanaraman B) J Biol Chem 2004 Apr 30;279(18):19099-112 57 Citations |
| 1 | Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study. (Elsinger CL, Rao SM, Zimbelman JL, Reynolds NC, Blindauer KA, Hoffmann RG) J Int Neuropsychol Soc 2003 Nov;9(7):1088-98 93 Citations |
| 1 | Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. (Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI) Genes Chromosomes Cancer 2003 Sep;38(1):40-52 122 Citations |
| 1 | Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. (Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS) Brain Res Mol Brain Res 2003 Jun 10;114(2):123-31 219 Citations |
| 2 | 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. (Kalivendi SV, Kotamraju S, Cunningham S, Shang T, Hillard CJ, Kalyanaraman B) Biochem J 2003 Apr 01;371(Pt 1):151-64 121 Citations |
| 1 | Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. (Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH) J Comp Neurol 2002 Aug 26;450(3):203-14 176 Citations |
| 1 | Interaction of levodopa and cues on voluntary reaching in Parkinson's disease. (Kelly VE, Hyngstrom AS, Rundle MM, Bastian AJ) Mov Disord 2002 Jan;17(1):38-44 35 Citations |
| 1 | Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. (El Sharkawi A, Ramig L, Logemann JA, Pauloski BR, Rademaker AW, Smith CH, Pawlas A, Baum S, Werner C) J Neurol Neurosurg Psychiatry 2002 Jan;72(1):31-6 239 Citations |
| 1 | Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. (Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG) Arch Neurol 2000 Oct;57(10):1461-3 124 Citations |
| 1 | The pedunculopontine nucleus and Parkinson's disease. (Pahapill PA, Lozano AM) Brain 2000 Sep;123 ( Pt 9):1767-83 696 Citations |
| 1 | Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. (Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD) Ann Neurol 1999 Sep;46(3):419-24 370 Citations |
| 1 | Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor. (Pahapill PA, Levy R, Dostrovsky JO, Davis KD, Rezai AR, Tasker RR, Lozano AM) Ann Neurol 1999 Aug;46(2):249-52 78 Citations |
| 1 | Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy. (Manley TJ, Chusid MJ, Rand SD, Wells D, Margolis DA) Pediatr Infect Dis J 1998 May;17(5):433-4 10 Citations |
| 1 | Transient resolution of bilateral tremor after unilateral thalamotomy, associated with focal injury of the corpus callosum: case report. (Greene KA, Wallace RC, Fram EK, Shetter AG, Lieberman AN) J Neurol Sci 1995 Mar;129(1):25-8 1 Citation |
| 1 | Novel heuristics of functional neural networks: implications for future strategies in functional neurosurgery. (Baev KV, Greene KA, Marciano FF, Shetter AG, Lieberman AN, Spetzler RF) Stereotact Funct Neurosurg 1995;65(1-4):26-36 1 Citation |
| 1 | Frontal and parietal lobe dysfunction in depression: delayed alternation and tactile learning deficits. (Freedman M) Neuropsychologia 1994 Aug;32(8):1015-25 36 Citations |
| 1 | Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. (Yu SJ, Lo ES, Cochran EJ, Lin DH, Faselis CJ, Klawans HL, Carvey PM) Exp Neurol 1994 Mar;126(1):15-24 27 Citations |
| 1 | Induction of mania by L-dopa in a nonbipolar patient. (Harsch HH, Miller M, Young LD) J Clin Psychopharmacol 1985 Dec;5(6):338-9 21 Citations |
